Hypersensitivity pneumonitis (HP) is an inflammatory lung disease that occurs in response to inhalation of various antigens found in the environment. This disease is characterized by a non-allergic but immune-mediated reaction that can lead to disruption of the structure and function of lung tissue. Hypersensitivity pneumonitis can be acute, subacute or chronic, depending on the duration and nature of exposure to the antigen. Clinical manifestations range from mild discomfort to severe respiratory distress, which makes timely diagnosis and treatment especially important.
History of the disease and interesting historical facts
Hypersensitivity pneumonitis was first described in 1932, when doctors found a link between inhaling organic materials and the development of lung disease in farmers. Researchers then began to classify the various forms of HP, focusing on occupational exposures to the lungs, such as working with bird feces (avian mycosis), dolphins (dolphinism), and moldy raw materials. Near the middle of the 20th century, it was discovered that not only occupational activities but also contact with potentially hazardous substances in the home environment could cause similar reactions. These discoveries contributed to the development of modern diagnostic and treatment methods for the disease.
Epidemiology
The epidemiology of hypersensitivity pneumonitis varies depending on the region and the working district at risk. According to studies, the incidence of this pathology in the population ranges from 1 to 9 cases per 100,000 people per year. In certain occupational groups, such as farmers, laboratory technicians, food industry workers and veterinary workers, the risks are significantly increased, reaching 5-15% cases per 1000 people. There is also a predominance of diseases in people aged 40-70 years.
Genetic predisposition to this disease
To date, no specific genes have been identified that are directly involved in the development of hypersensitivity pneumonitis. However, some studies suggest a certain genetic predisposition to this disease associated with mutations in genes responsible for the immune response, such as human leukocyte antigen (HLA) genes, which may increase the likelihood of developing the disease when exposed to provoking antigens. The characteristics of HLA genotypes may affect the clinical manifestations of GP and their severity in individual patients.
Risk factors for the development of this disease
Risk factors that contribute to the development of hypersensitivity pneumonitis can be divided into physical and chemical. Physical factors include:
- Long-term or repeated exposure to organic materials: bird droppings, mold, wood dust.
- Exposure at work in specific environments such as farms and livestock complexes.
- Inadequate storage and processing conditions for food products.
Chemical risk factors include:
- Exposure to toxic chemicals such as isocyanates, formaldehyde and ammonia.
- Professional use of adhesives and paints containing volatile organic compounds.
Concomitant conditions, such as immune system dysfunction, allergic reactions, or the presence of previous respiratory diseases, can also play an important role in the development of the disease.
Diagnosis of this disease
Diagnosis of hypersensitivity pneumonitis involves several key steps. The main symptoms can vary and include:
- Short-term or chronic respiratory symptoms (cough, shortness of breath, chest pain).
- General symptoms (fever, fatigue, weight loss).
Laboratory tests may include:
- General blood test to detect inflammatory changes.
- Tests for specific antibodies to potential antigens.
Radiological examinations such as chest X-ray and CT scan help to detect changes in lung tissue and determine the degree of inflammation. Other diagnostics may include bronchoscopy and transbronchial biopsy to rule out other diseases. Differential diagnosis includes pathologies such as infectious pneumonia, sarcoidosis and allergic pneumonitis.
Treatment
Treatment of hypersensitivity pneumonitis is aimed at eliminating the effects of the antigen and reducing inflammatory changes in the lungs. General recommendations include:
- Avoid contact with the identified allergen.
- Compliance with humidity and ventilation conditions in the premises.
Pharmacological treatment may include:
- Corticosteroids to reduce inflammation and symptoms.
- Immunosuppressive drugs for severe forms of the disease.
Surgical treatment may be considered in rare cases where severe changes in lung tissue are observed. Other treatments include breathing exercises, oxygen therapy, and the use of bronchodilators to improve airway patency.
List of medications used to treat this disease
The most commonly used drugs to treat hypersensitivity pneumonitis include:
- Prednisolone
- Methylprednisolone
- Azathioprine
- Cyclophosphamide
- Monoclonal antibodies (eg, rituximab)
Disease monitoring
Monitoring of patients with hypersensitivity pneumonitis includes periodic assessment of clinical symptoms and medical history, as well as regular radiographic and pulmonary function tests to assess the progression of the condition. It is important to monitor respiratory function to identify potential complications in a timely manner. The prognosis depends on the stage of the disease and the timeliness of diagnosis, with early treatment potentially improving quality of life. Complications may include the development of interstitial pulmonary fibrosis and chronic respiratory failure.
Age-related features of the disease
Hypersensitivity pneumonitis can occur in different age groups, from childhood to the elderly. In children, the disease may manifest itself as shortness of breath and cough after contact with allergens such as pollen or mold. In adults, the chronic form is most often encountered, and the elderly are more likely to develop severe forms of the disease with a high probability of complications. The conditions for timely diagnosis and treatment for each age group may differ.
Questions and Answers
- What causes hypersensitivity pneumonitis?
Hypersensitivity pneumonitis is caused by inhaling various antigens such as mold, bird feces, and toxic chemicals. - How is this disease diagnosed?
Diagnosis of hypersensitivity pneumonitis involves clinical history, laboratory tests, radiologic examinations, and sometimes bronchoscopy. - What are the symptoms of hypersensitivity pneumonitis?
Symptoms include cough, shortness of breath, fever and fatigue, which can range from mild to severe. - Can hypersensitivity pneumonitis be cured?
Treatment can be successful with timely elimination of contact with the allergen and the use of adequate drug therapy, however, in chronic forms the disease can be recurrent. - What is the prevention of the disease?
Prevention includes avoiding known contact with allergens and maintaining indoor sanitation.
Dr. Oleg Korzhikov recommends that all patients with hypersensitivity pneumonitis monitor their health and undergo regular examinations. “It is important to pay attention to changes in your body, especially if you have risk factors, and to contact a doctor immediately if symptoms appear. Following simple preventive measures, such as using respirators when working with potentially hazardous substances and keeping your home clean, can significantly reduce the risk of relapses and complications.”
